Robert Flavell, MD, PhD, Author at Grand Rounds in Urology

Robert Flavell, MD, PhD

University of California

San Francisco, California

Dr. Flavell is the Chief of Molecular Imaging and Therapeutics Clinical Section in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco (UCSF). He is also an Assistant Professor of Radiology at UCSF. Dr. Flavell received his medical degree from Weill Cornell Medical College, and his PhD from Rockefeller University as part of the Tri-Institutional MD-PhD program. He completed his one-year internship at Memorial Sloan Kettering Cancer Center in New York. Dr. Flavell then went on to complete a four-year Diagnostic Radiology Residency at UCSF, where he also finished a Nuclear Medicine Fellowship. Dr. Flavell is an expert in nuclear medicine, molecular imaging, and therapeutics. His laboratory, the Molecular Imaging Lab, focuses on the development of new molecular imaging tools for better understanding of disease progression in patients with prostate and other cancers. Dr. Flavell is an author on over 50 peer-reviewed publications and has been widely recognized for his research.

Disclosures:

Talks by Robert Flavell, MD, PhD

Incorporating New PET Imaging and Theranostic Approaches into Prostate Cancer Practice | Interesting Cases

Posted by Robert Flavell, MD, PhD | Jul 2018

Robert R. Flavell, MD, offers an introductory overview of theranostics and advances in nuclear imaging and therapies, especially prostate-specific membrane antigen (PSMA) agents. Subsequently, he leads a panel with Susan F. Slovin, MD, PhD, E. David Crawford, MD, and Phillip J. Koo, MD in reviewing four distinct prostate cancer cases, sharing their thoughts and recommendations with regard to use of recently developed imaging agents and therapies.

Robert Flavell, MD, PhD

University of California

San Francisco, California

Talks by Robert Flavell, MD, PhD

Incorporating New PET Imaging and Theranostic Approaches into Prostate Cancer Practice | Interesting Cases

Join the GRU Community

You have Successfully Subscribed!